| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
You are here Biopharmaceutical/ Genomic Glossary Homepage/Search > >Pharmaceutical Applications guide & Site Map 21st
century drug discovery & development glossaries & taxonomies Site map Not a comprehensive list of terms, but a
quick and dirty finding aid while I'm working on getting these glossaries into a
(long overdue) searchable database. CHI’s Drug Discovery and Development Map 21st century drug discovery drug development & drug safety map Biomarkers biological markers, biosignatures, bridging biomarkers, disease markers, efficacy biomarkers, genetic biomarkers, protein biomarkers, serum biomarkers, surrogate ... , type 0 biomarkers, type I biomarkers, type II biomarkers Business
of biopharmaceuticals attrition,
benchmarking, best practices, big pharma, bioentrepreneur, biotechnology ...,
blockbusters, business models, competitive ..., core competencies, deals,
disintermediation, disruptive technologies, elevator pitch, FIPCO, franchises,
GICS, genomics ..., high tech
industry, hypercompetitive, lead users, market ..., megabrands, multibusters,
optimization, outpartnering, outsourcing, pharmaceutical ..., platform ...,
price trends, productivity ..., proof of concept, proof of principle, portfolio,
risk, sexy technologies, start-ups, technology ..., white space
Drug
discovery & development blockbuster drugs, bottlenecks,
developability, drug
discovery ..., drug development, drug-like, drug- likeness, druggable, high throughput, LIMS, lifestyle
drugs, molecular recognition, peptidomimetic,
pharmaceutical..., pharming, pipeline problem, preclinical, protein delivery, protein
therapeutics, rational drug design, reverse pharmacology, reverse
vaccinology, robot...,
samples..., small molecules, vaccines Pharmaceutical
biology affinity, agonist, antagonist, antibody, antisense, binding
sites, chiral, efficacy, enzymes, enzymes and coenzymes, epitope, G-protein,
homologue, hormone, hydrophilicity, hydrophobicity, immunotoxins, ligand,
lipophilicity, metabolite, molarity, monoclonal antibodies, PAT Process Analytical Technology,
pharmacophore, promiscuous inhibitors, receptors, recognition site, recombinant
..., solubility, substrate, vaccine Drug safety & pharmacovigilance adverse drug event ADE, adverse drug reaction ADR, ED 50, evidence based toxicology, idiosyncratuc toxicity, molecular toxicology, pharmacoepidemiology, phase IV post marketing surveillance, post approval drug safety, predictive ADME, predictive toxicogenomics, PSURs, side effect, susceptibility, systems toxicology, therapeutic index, tox chips, toxicogenomics, toxicoinformatics, toxicology, toxicoproteomics, toxins, xenobiotic Drug Targets compound ..., disease targets, drug targets, gene targeting, gene targets, GPCRs G protein coupled receptors, HDAC histone deacetylase Inhibitors, intracellular ..., ion channels, kinases, molecular targets, nuclear hormone receptors, protein targets, target ..., target validation, tissue targeting, tractable targets Molecular Medicine BSE, behavior genomics, biomedical ..., blood, CJD, camera pill, cardiogenomics, channelopathies, chronome, chronotherapy, clinical proteomics, combination therapies, cryomedicine, cryotherapy, determinism, diagnosis, diagnostics, disease... , epidemiology, epigenomics, gene therapy, genetic medicine, genetics, genomic drugs, immunoinformatics, immunotechnology, immunotherapy, medical informatics, medical proteomics, molecular ..., neurogenomics, normal, nutriceuticals, pathogenomics, pathology informatics, personal genomics, predictive, preventive, prognosis, psychoneuroimmunology, public health, research diagnostics, TSE, therapeutics, translational medicine, uncertainty, vCJD, world health Patient resources Cancer genomics CGAP, cancer ..., chemoprediction, cryochemotherapy, familial cancer, Gleevec, Herceptin, hereditary cancer, molecular events, molecular targets, molecular taxonomy, oncogene, oncogenomics, oncoproteomics, p53 ,,,, sporadic cancer, tumor markers, tumor suppressor genes, viral oncogene Genetic & genomic testing analytical sensitivity, analytical specificity, clinical sensitivity, clinical specificity, family history, genetic discrimination, genetic enhancement, genetic privacy, genetic test, genomic testing, germline mutation, "good genes", "bad genes", preconception testing, predictive testing, predisposition, preimplantation diagnosis, presymptomatic, risk communication, screening, somatic cells, susceptibility Pharmacogenomics ADME ..., ADME/Tox, DME genes, DMPK, drug metabolism, drug response, ED50, endocrine disrupters, enzyme kinetics, genotype-to phenotype, hepatotoxicity, immunophenotyping, in silico pharmacology, individualized medicine, kinetic outliers, mechanism of action, metabonomics, microdosing, mode of action MOA, molecular toxicology, NIEHS, personalized medicine, pharmacodynamics, pharmacogenetics, pharmacokinetics, pharmacoproteomics, phenotype ..., predictive ..., reverse pharmacology, systems pharmacology, systems toxicology, target haplotype, tox- chips, toxicogenomics, toxicoproteomics, xenobiotic Bibliography
|
